LAB
Standard BioTools Inc

5,646
Loading...
Loading...
News
all
press releases
Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates
Standard BioTools (LAB) delivered earnings and revenue surprises of 0.00% and +5.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
More News
News Placeholder
Doximity (DOCS) Q1 Earnings and Revenues Top Estimates
Doximity (DOCS) delivered earnings and revenue surprises of +16.13% and +4.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic
ILMN jumps 2.9% after striking a $350M deal to acquire SomaLogic and boost its fast-growing multiomics strategy.
Zacks·3mo ago
News Placeholder
Standard BioTools And 2 Other Penny Stocks Executives Are Buying
read more...
Benzinga·1y ago
News Placeholder
Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying
read more...
Benzinga·1y ago
News Placeholder
Standard BioTools initiated with bullish view at Jefferies, here's why
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan Platform for Translational Medicine Research
SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB), driven by a bold purpose Unleashing tools to accelerate breakthroughs in human health today...
Globe Newswire·1y ago
News Placeholder
Standard BioTools (NASDAQ:LAB) Shares Up 6.9%
Standard BioTools Inc. (NASDAQ:LAB Get Free Report)s stock price rose 6.9% on Thursday . The stock traded as high as $2.81 and last traded at $2.80. Approximately 954,671 shares were...
Ticker Report·2y ago
News Placeholder
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
SOUTH SAN FRANCISCO, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. ( Standard BioTools or the Company ) (Nasdaq: LAB) today announced that it has exchanged all outstanding...
Globe Newswire·2y ago
News Placeholder
Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript
Standard BioTools Inc. (LAB) Q4 2023 Earnings Call Transcript...
Seeking Alpha: Transcripts·2y ago

Latest LAB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.